Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02164058
NCT02164058
Withdrawn
Not Applicable

A Randomized Controlled Multicenter Study on the Use of the TandemHeart to Reduce Infarct Size

CardiacAssist, Inc.0 sitesJanuary 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAcute Myocardial Infarction

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Myocardial Infarction
Sponsor
CardiacAssist, Inc.
Primary Endpoint
Primary Safety
Status
Withdrawn
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

The purpose of this study is to determine if a device known as the TandemHeart® System (TandemHeart) can help limit heart damage and reduce serious complications after a certain type of heart attack (acute ST elevation anterior wall myocardial infarction [STEMI]) by evaluating the use of the TandemHeart system prior to a procedure called percutaneous coronary intervention (PCI)

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
February 2017
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Primary Safety

Time Frame: 30 days post-procedure

Major Adverse Cardiac or Cerebrovascular Events (MACCE): * Death, all cause * Stroke * Reinfarction * Major vascular complications

Similar Trials

Terminated
Not Applicable
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart TransplantationHeart FailureCardiac FailureCongestive Heart FailureHeart Failure, Left-sided
NCT02205411ReliantHeart Inc.17
Not yet recruiting
Not Applicable
Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus BradycardiaSinus Bradycardia
NCT05021627Shanghai Chest Hospital240
Completed
Not Applicable
Teaching Inhaler Use With the INCA Device in a Community Pharmacy SettingAsthmaPulmonary Disease, Chronic Obstructive
NCT02203266Beaumont Hospital152
Unknown
Not Applicable
Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical StudyCoronary Artery DiseaseAntineoplastic Agents
NCT03284255Shanghai Bio-heart Biological Technology Co., Ltd.431
Completed
Phase 3
Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)Diabetes Mellitus, Type 2
NCT00087516Merck Sharp & Dohme LLC741